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Abstract: This systematic review is aimed at evaluating the effectiveness of synthetic block materials
for bone augmentation in preclinical in vivo studies. An electronic search was performed on Pubmed,
Scopus, EMBASE. Articles selected underwent risk-of-bias assessment. The outcomes were: new
bone formation and residual graft with histomorphometry, radiographic bone density, soft tissue
parameters, complications. Meta-analysis was performed to compare new bone formation in test
(synthetic blocks) vs. control group (autogenous blocks or spontaneous healing). The search yielded
214 articles. After screening, 39 studies were included, all performed on animal models: rabbits (n= 18
studies), dogs (n = 4), rats (n = 7), minipigs (n = 4), goats (n = 4), and sheep (n = 2). The meta-analysis
on rabbit studies showed significantly higher new bone formation for synthetic blocks with respect to
autogenous blocks both at four-week (mean difference (MD): 5.91%, 95% confidence intervals (CI):
1.04, 10.79%, p = 0.02) and at eight-week healing (MD: 4.44%, 95% CI: 0.71, 8.17%, p = 0.02). Other
animal models evidenced a trend for better outcomes with synthetic blocks, though only based on
qualitative analysis. Synthetic blocks may represent a viable resource in bone regenerative surgery
for achieving new bone formation. Differences in the animal models, the design of included studies,
and the bone defects treated should be considered when generalizing the results. Clinical studies are
needed to confirm the effectiveness of synthetic blocks in bone augmentation procedures.
Keywords: animal models; biomaterials; block graft; bone graft; bone regeneration; bone substitutes;
histological analysis; synthetic biomaterials; systematic review
1. Introduction
The restoration of damaged tissues represents the main goal of contemporary medical research [1].
The ideal goal is a newly developed tissue with the same immunological, functional, structural, and
mechanical characteristics as the native one [2,3]. In oral and maxillofacial surgery, achieving bone
regeneration is necessary to allow a predictable prosthetic rehabilitation supported by dental implants
in the case of severe bone defects [4,5].
Though autologous bone is still considered the best grafting material for bone regeneration
purposes, the main clinical drawbacks are the limited quantity available and the morbidity of the
donor site, which requires careful management [6]. In order to address such issues, bone regeneration
procedures in oral and maxillo-facial surgery take advantage of mechanical and biological properties of
various types of bone substitute scaffolds to improve the healing process of damaged hard tissues [7].
Many biomaterials and surgical techniques have been developed and may be safely used for
bone regeneration [8,9]. The selection of the appropriate biomaterial cannot neglect the knowledge
of its properties and behavior in order to achieve a predictable result and clinical success of the
regenerative procedure. The three-dimensional structure of the scaffolds plays a crucial key role in
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bone regeneration [3,10]. In this way, biomaterials should provide a provisional tridimensional guide
and a mechanical support to the cells active in the early stages of bone regeneration [10,11]. Porosity,
topography, chemical surface composition, 3D architecture, immunogenicity, and mechanical features
significantly influence the bone formation [12].
The integration of a biomaterial with the host tissue occurs through different mechanisms, such as
osteogenesis, osteoconduction, and osteoinduction [13]. Even though autologous bone shows all these
characteristics and is considered as the golden standard of grafting material, several drawbacks have
limited its use in relation to the morbidity of the donor site [14].
Therefore, different osteoconductive biomaterials have been developed and several studies showed
that they may favor cell attachment and proliferation, improving both quantitatively and qualitatively
the bone regeneration by promoting physiological healing at the bone defect and forming a mature
tissue with adequate mechanical properties [5,9,10]. Engineering of synthetic bone graft substitute has
been indicated as a promising alternative to the autograft methods [6,8]. Indeed, synthetic bone graft
substitutes have been successfully used for vertical ridge augmentation prior to implant placement.
An ideal synthetic biomaterial should be biocompatible, resorbable, showing a minimal fibrotic
reaction, able to undergo remodeling and support new bone formation, cost-effective, and easy to
use [15]. From a mechanical point of view, synthetic bone graft substitutes should have a similar
strength to that of the cortical/cancellous bone being replaced [16]. Different synthetic biomaterials
are currently used in bone regeneration and can be classified into three groups according to their
composition: metallic (NiTi and MgF2 alloy), ceramic (Hydroxyapatite (HA, Bioglass), and polymeric
(polylactic-co-glycolic acid (PLGA), polycaprolactone (PCL), polyglycolic acid (PGA), polylactic acid
(PLA)) [16,17].
The synthetic ceramic biomaterials have good compressive strengths but they are weak in tension
and shear, brittle, and fracture-prone on shock loading [18]. On the contrary, synthetic HA in solid block
form is difficult to shape, does not permit fibro-osseous ingrowth, and has a much higher modulus
of elasticity than bone [19]. Graft microporosity is able to bioactively influence the differentiation
and functional activity of cells in vitro involved in the physiological events related to the osteogenic
processes [20,21]. Polymeric materials, such as acrylic bone cements, have been proposed for the
treatment of bone defects in orthopedics and implantology, due to their favorable microstructure and
bioactivity properties [22].
Moreover, the metallic materials application should be limited to a contained area due to the
modulus of elasticity higher than the bone [19]. An ideal biomaterial should have similar modulus
of elasticity to that of bone in an attempt to prevent stress shielding as well as maintain adequate
toughness to prevent fatigue fracture under cyclic loading [7–9].
The polymeric materials are more beneficial than others because of their biocompatibility,
mechanical properties, microstructure, and degradation rate, and these properties can even be precisely
controlled by composition and fabrication of scaffold polymer materials [23].
The aim of this study was to perform a systematic literature review of preclinical in vivo studies
with the objective to determine which are the indications deriving from research of the most effective
synthetic bone block materials for bone augmentation techniques. The PICO (Problem, Intervention,
Comparison, Outcome) question of this review was: Are synthetic bone blocks effective for the
treatment of bone defects with respect to other graft materials or ungrafted sites?
2. Results
The electronic search procedure is presented in Figure 1. The database analyses generated a total
of 182 references. A manual search was also performed and a total of 32 articles were added to the
output article list, generating a total of 214 articles retrieved. After title and abstract evaluation, 175
articles were excluded: 2 articles written in Chinese language, 6 clinical case series/case report studies,
49 in vitro articles, 19 literature reviews, 84 articles nonpertinent to the topic, and 15 studies where a
combination with autogenous bone particles was used.
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Figure 1. Flowchart of the study selection process (adapted from PRISMA guidelines [24]).
At the end of the procedure, 39 articles satisfied the inclusion criteria and were included in this
review analysis: 18 studies were performed in a rabbit study model, 4 on dogs, 7 on rats, 4 on minipigs,
4 on goats, and 2 articles on sheep (Figure 1).
No study on humans was included. The main characteristics of the defect treated, bone
graft material characteristics, study outcome, and follow-up time for each animal model are
summarized in Tables 1–6. Thirty-seven studies (97.3%) performed histologic evaluation of the samples
retrieved [18,25–60], 26 studies (68.4%) reported histomorphometric analysis, 1 study performed
fluorescence microscopy analyses of bone samples [18]. Two studies [47,56] described a scanning
electron microscope (SEM) evaluation. Eleven articles [28–32,39,40,51,54,59,61] also performed
microcomputed tomography (micro-CT), five a radiographic assessment [18,38,44,55,62], and one
article [50] reported an angiogram evaluation. One study also reported X-ray diffraction evaluation [42].
An analytic description of the evaluation techniques is provided in Tables 1–6.
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Table 1. General features of the 18 studies performed in a rabbit study model.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Rabbit
Torres et al. 2011 [25] 8 Calvaria Monetite in different thickness - 8 weeks Histology andHistomorphometry
Zivadinovic et al.
2016 [26] 8 Calvaria β-tricalcium phosphate
Unfilled, Autologous
graft 4 weeks
Histology and
Histomorphometry
Tamimi et al. 2009 [27] 8 Calvaria Monetite Autologous graft 8 weeks Histology andHistomorphometry
Kim et al. 2012 [63] 16 Calvaria Block-type biphasic calcium phosphate(BCP), rhBMP-2, collagene - 8 weeks
Histology and
Histomorphometry
Hwang et al. 2012 [28] 10 Calvaria
Hydroxyapatite, β-tricalcium phosphate,
Biphasic calcium phosphate synthetic
block-type bone graft
Unfilled 4–8 weeks micro-CT, Histology andHistomorphometry
Bae et al. 2014 [29] 16 Calvaria Hydroxyapatite bone block Autologous graft 4–8 weeks micro-CT, Histology andHistomorphometry
Shim et al. 2012 [30] 18 Calvaria
polycaprolactone(PCL)/poly(lactic-co-glycolic
acid) (PLGA) scaffold blended with
tri-calcium phosphate (TCP)
Unfilled 4–8 weeks micro-CT, Histology andHistomorphometry
Xu et al. 2008 [31] 12 Calvaria
β-calcium silicate (b-CaSiO3, b-CS), porous
β-tricalcium phosphate (b-Ca3(PO4)2; β
-TCP
- 4–8 and 16 weeks micro-CT, Histology andHistomorphometry
Yoo et al. 2017 [32] 7 Calvaria
Biphasic calcium phosphate(BCP);
Biphasic calcium phosphate
phosphate/carboxymethyl cellulose
(BCP/CMC);
Biphasic calcium phosphate/cross-linked
carboxymethyl cellulose (BCP/c-CMC);
Biphasic calcium phosphate/hyaluronic acid
(BCP/HyA)
- 4 weeks micro-CT, Histology andHistomorphometry
Lam et al. 2009 [34] 6 Calvaria
PCL scaffolds (NaOH treated for 12h);
Predegraded PCL scaffolds (PD-PCL, NaOH
treated for 7 days); Untreated
PCL/TCP scaffolds
- 18–24 weeks Histology
Gehrke et al. 2019 [35] 20 Calvaria Sintered bovine bone blocksNonsintered bovine bone blocks - 6 and 8 weeks
Histology and
Histomorphometry
Kanazawa et al. 2017
[61] 19
Femur and
tibia defects
Carbonate apatite (CO3Ap);
Hydroxyapatite (HA) block -
4, 12,
and 24 weeks micro -CT
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Table 1. Cont.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Tsai et al. 2008 [36] 16 Femur defects
CPC (amorphous calcium phosphate, DCPD
powders mixed with physiological saline) in
different concentration
- 1, 4, 12, and24 weeks Histology
Teramoto et al.
2005 [37] 38 Femur defects
β-tricalciumphosphate (75% porosity);
Apatite-wollastonite glass-ceramic (70, 80,
and 90% porosity)
- 8, 12, 24, and36 weeks Histology
Ohsawa et al.
2004 [38]
3 Femur
defects
Porous apatite
Wollastonite-
containing
glass-ceramic
(AW)
- 3, 6, 12 months Radiographs,Histology
Guo et al. 2012 [39] 6
Mandible
defects (angle
and body)
Composite nano-HA/polyamide (n-HA/PA);
Composite n-HA/PA+ BMSC bone marrow
stromal cells
- 4–12 weeks
Histology,
Histomorphometry, SEM,
micro-CT
Zhang et al. 2009 [40] 12 Radius defects
Nanocomposite of hydroxyapatite
surface-grafted with poly(L-lactide and
Poly- Glycolidee (g-HAP)
- 4, 8, 12, and20 weeks Radiographs, Histology
Table 2. General features of the four studies performed on dogs.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Dogs
Rismanchian et al.
2015 [41] 4
Maxillary
defects
Bioglass (BG), Demineralized bone matrix
(DBM), Forstrite (FR) Unfilled
15, 30, 45, and 60
days
Histology and
Histomorphometrry
Du et al. 2015 [42] 4
Mandibular
critical-size
defect
Nano Hydroxyapatite (nHA) coral blocks;
recombinant human vascular endothelial
growth factor165 (rhVEGF), Nano
Hydroxyapatite (nHA)/coral blocks
- 3 and 8 weeks Histology,Histomorphometry
Nery et al. 1992 [43] 21
Mandibular
and maxillary
periodontal
defects
(Canines and
1st molar)
Hydroxyapatite/beta tricalcium phosphate
(HA/ßTCP) in different macroporosity,
Biphasic calcium phosphate ceramic
Unfilled 6 months Histology,Histomorphometry
Erbe et al. 2001 [44] 4
Cylindrical
metaphyseal
defects
B-TCP synthetic cancellous bone - 12, 24, and 52week
Radiograph,X-ray
diffraction (XRD),
Histology and
Histomorphometry t 12,
24, and 52 week
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Table 3. General features of the seven studies performed on rats.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Rats
Gabbai-Armelin et al.
2015 [45] 60 Tibia defect Bioactive fibrous glassy scaffold Unfilled 15, 30, and 60 days
Histology,
Histomorphometry
Coraca et al. 2008 [46] 44 Tibia defect Poly(l-lactic acid)PLLA/poly(ethyleneoxide) PEO blend, poly(l-lactic acid) PLLA - 2, 4, 6, 8 weeks
Histology,
Histomorphometry
Inzana et al. 2014 [47] 18 Femuraldefect
Calcium phosphate scaffold; CPh scaffold,
collagen binder; CPh scaffold collagen
coating; Devitalized allograft
Unfilled 9 weeks
Histology,
Histomorphometry, SEM
evaluation
Hwang et al. 2017 [62] 32 Calvaria
Polycaprolactone(PCL)
polylactic-co-glycolic acid PLGA)
β-tricalcium phosphate in a 4:4:2 ratio,
Biphasic calcium phosphate
- 2, 4, 6, 8 weeks Histology,Histomorphometry
Montjovent et al.
2007 [48] 24 Calvaria
Bioresorbable scaffolds made of polylactic
acid/beta tricalcium phosphate;
PLa/Hydroxyapatite; Beta tricalcium
phosphate
- 18 weeks Radiographs, Histology
Hulsart-Billström et
al. 2011 [49] 18
Ectopic bone
formation
Beta tricalcium phosphate (ß-TCP)/nano
hydroxyapatite, hydroxyapatite, Clods of
hydroxyapatite, HAP biomimetic
Unfilled 4 weeks Radiographs, Histology
do Carmo et al.
2017 [50] 20
Maxillary
dental socket
Nanostructured carbonated
hydroxyapatite/sodium alginate 5%
strontium microspheres, Nanostructured
carbonated hydroxyapatite/sodium alginate
- 1 and 6 weeks Histology
Table 4. General features of the four studies performed on minipigs.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Minipigs
Yeo et al. 2011 [51] 10 Mandiblelateral defect PCL-TCP scaffold, Collagen membrane
Autologous graft+
collagen membrane 24 weeks
micro-CT, Histology and
Histomorphometry
Kirchhoff et al.
2011 [52] 6
Mandible
defect
Nanostructured hydroxyapatite (HA)
porous matrix of silica (SiO2) gel Autologous graft 5 and 10 weeks
Histology,
Histomorphometry
Henkel et al. 2006 [53] 15
Critical-size
mandible
defects
CaP matrix (HA:TCP = 60%:40%);
Monophasic CaP matrix (HA: 100%),
Pure hydroxyapatite; Beta tricalcium
phosphate Gelatin sponge
- 32 weeks Histology,Histomorphometry
Verket et al. 2016 [54] 5
Implants with
dehiscence
defects
TiO2 scaffold Autologous graft 12 weeks
Histology,
Histomorphometry
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Table 5. General features of the four studies performed on goats.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Goats
Nandi et al. 2009 [55] 12 Radius defects Porous bioactive glass blocks Unfilled 90 days Histology, Radiographsand Angiogram
Habibovic et al.
2008 [56] 12
Lumbar
transverse
processes
BCPA, BCPB, BCPC, one composite (BCPCþ)
of BCPC reinforced with PLA, HA, and CA
ceramic.
- 3, 6, 9, and 12weeks
Histology,
Histomorphometry
Habibovic et al.
2008 [57] 12
Transverse
processes
(L1–L4)
Ceramic tricalcium phosphate (TCP)
brushite, monetite - 3, 6, and 9 weeks
Histology, and
Histomorphometry, SEM
evaluation
Koeter et al. 2008 [58] 20 Knee defects Coralline hydroxyapatite (CHA) Autologous bone 12 weeks Histology,Histomorphometry
Table 6. General features of the two studies performed on sheep.
Authors N. Animals Defect Test Block Control Site Analysis Time Evaluation
Studies on Sheep
von Doernberg et al.
2006 [59] 9
Methaphysial
or epiphysial
long bones
Beta-TCP cylinders at different pore size Unfilled 90 days Histology, Radiographsand Angiogram
Gosain et al. 2004 [60] 10 Calvaria
60% hydroxyapatite and 40%-TCP;
60% hydroxyapatite–cement and 40%-TCP;
20% hydroxyapatite–cement and 80%-TCP;
Pure hydroxyapatite;
- 3, 6, 9, 12 weeks Histology,Histomorphometry
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2.1. Risk-of-Bias Assessment
Risk-of-bias ratings across all included articles is presented in Figure 2. Only 10
studies [25,30,37,41,55,56,61] were classified as having a low risk of bias, whereas all other included
studies presented a high risk of bias, based on the parameters evaluated (Figure 3).
Figure 2. Risk-of-bias graph: review authors’ judgments about each risk-of-bias item presented as
percentages across all included studies. + = yes (the criteria was met, green circle); − = no (the
criteria was not met, red circle); ? =unclear if the criteria was met or not (yellow circle). The figure
was created using RevMan Version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, 2014).
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Figure 3. Risk-of-bias summary: review authors’ judgments about each risk-of-bias item for each
included study. The colors have the same meaning as in Figure 2. The figure was created using RevMan
Version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2014).
Among them, the studies selected showed a wide heterogeneity about the study design, analytical
methods, and follow-up period. Erbe et al. reported the longest follow-up period in a study on dog
bone defects [44]. The unfilled defect represented the most diffused experimental control site of the
studies selected for the review.
2.2. Meta-Analysis
Following data extraction, four comparative studies were identified that provided the
histomorphometric results of new bone formation in different animal models using synthetic bone
blocks versus a control group in which the defect was left to heal spontaneously [26,28,30,41]. In one
study, autogenous bone graft was used as the control [27]. The data were grouped according to the
follow-up duration: four weeks and longer than four (mostly eight) weeks. Table 7 shows the data
extracted from these studies: four studies were performed on rabbits, one each on dog model, rat, sheep,
and minipig. Since bone features and healing rate of different animal models present considerable
differences, and due to the fact that for some animals only one study was found, a meta-analysis was
performed only for studies based on the rabbit model. One of such studies used autogenous bone
block as the control [64] and was excluded from the meta-analysis, aiming at comparing synthetic
blocks versus unfilled sites. The results of the meta-analysis, synthesized in the Forest plot in Figure 4,
showed that there is evidence for a significantly higher new bone formation in the groups using bone
blocks as compared to the control group. The difference appears to smoothen slightly at the longer
follow-up. It must be noted, however, that a significant heterogeneity was found among studies at both
follow-ups. About half of the comparisons showed a nonsignificant effect, while one study reported a
higher new bone formation in the control group [45].
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Table 7. Synthesis of the histomorphometric results relative to new bone formation (NBF) at four and eight weeks of healing in the included studies that provided such
information. Only studies comparing a synthetic block versus unfilled control defect were considered. Only the five studies on rabbits were submitted to meta-analysis.
Author N. TEST Model TEST Mean% NBF TEST SD TEST N CTR Mean% NBF CTR SD CTR CTR Mean Difference% (95% CI)
Zivadinovic et al. 2016 [26] 8 Rabbit (β-TCP) 30.15% (4 weeks) 5.71 8 7.32 % (4 weeks) 8.40 UNFILLED 22.83 (15.79, 29.87)
Tamimi et al. 2009 [27] 8 Rabbit (monetite) 43.4% (8 weeks) 8.1 8 60.1% (8 weeks) 6.0 AUTOLOGOUS −16.30 (−23.29, −9.31)
5 Rabbit (HA) 4.97% (4 weeks) 1.91 0.98 (−1.17, 3.13)
5 Rabbit (β-TCP) 1.56% (4 weeks) 1.32 −2.43 (−4.21, −0.65)
5 Rabbit (BCP) 5.60% (4 weeks) 3.93
5 3.99% (4 weeks) 1.54 UNFILLED
1.61 (−2.09, 5.31)
5 Rabbit (HA) 6.95% (8 weeks) 3.51 2.40 (−1.38, 6.18)
5 Rabbit (β-TCP) 4.04% (8 weeks) 1.39 −0.51 (−3.02, 2.00)
Hwang et al. 2012 [28]
5 Rabbit (BCP) 9.03% (8 weeks) 3.39
5 4.55% (8 weeks) 2.50 UNFILLED
4.48 (0.79, 8.17)
Shim et al. 2012 [30]
6 Rabbit (PCL/PLGA) 10.74% (4 weeks) 1.86
6 4.06% (4 weeks) 2.03 UNFILLED
6.68 (4.48, 8.88)
6 Rabbit (PCL/PLGA/TCP) 14.29% (4 weeks) 4.59 10.23 (6.21, 14.25)
6 Rabbit (PCL/PLGA) 15.68% (8 weeks) 2.89
6 10.08% (8weeks) 1.86 UNFILLED
5.60 (2.85, 8.35)
6 Rabbit (PCL/PLGA/TCP) 20.75 % (8 weeks) 4.20 10.67 (6.99, 14.35)
4 Dog (BG) 22.65% (8 weeks) 2.76 −0.78 (−6.60, 5.04)
4 Dog (FR) 26.65% (8 weeks) 4.51 4
23.43% (8 weeks) 5.26 UNFILLED 3.22 (-3.57, 10.01)
4 Dog (BG) 21.21 (4 weeks) 0.94 −1.16 (−4.65, 2.33)Rismanchian et al. 2015 [41]
4 Dog (FR) 26.56 (4 weeks) 6.97 4
22.37 (4 weeks) 3.44 UNFILLED 4.19 −3.43, 11.81)
Gabbai-Armelin et al. 2015 [45] 60 Rat (BG) 21.3 % (8 weeks) 2.4 60 46.8% (8 weeks) 7.1 UNFILLED −25.50 (−27.40, −23.60)
10 Sheep (60%HA-CC) 13.6% (1 year) 2.0 N.E.
10 Sheep (60%HA-CP) 11.2% (1 year) 2.3 N.E.
10 Sheep (20%HA-CP) 28.5% (1 year) 4.5 N.E.Gosain et al. 2004 [60]
10 Sheep (100%HA-CP) 4.8% (1 year) 1.4
10 0 (1 year) 0 UNFILLED
N.E.
Kirchhoff 2010 [52]
6 Minipig (nHA-A) 7.6% (5 weeks) 6.0
- - - NO
CONTROL
N.E.
6 Minipig (nHA-B) 15.3% (5 weeks) 8.3 N.E.
6 Minipig (nHA-A) 34.1% (10 weeks) 10.8 N.E.
6 Minipig (nHA-B) 39.9% (10 weeks) 13.5 N.E.
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Figure 4. Forest plot showing the meta-analysis of the comparative studies performed in rabbits, with
a follow-up of four and eight weeks. The results demonstrate evidence for a significantly higher new
bone formation in the group using synthetic blocks. The figure was created using RevMan Version 5.3
(The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2014).
2.3. Studies Not Included in the Meta-Analysis
In spite of the large heterogeneity in the choice of the experimental site, from calvaria to long
bones, intraoral regions, or other skeletal or ectopic sites, and considering the different animal models,
the different materials, and the different techniques to assess the performance of the tested materials,
most studies reported favorable results when using synthetic blocks for bone defect regeneration.
In rabbits, the most used experimental site was the calvaria (12 out of 18 studies), followed by
long bone defects (tibia, femur, radius), while one study assessed mandibular defects (Table 1). In one
study, the control group, represented by autogenous bone, showed markedly better histomorphometric
results than the experimental group [27], while in the other studies, in which the control was the
unfilled defect, generally better outcomes were achieved using synthetic bone blocks (Table 7).
In dogs, three studies evaluated intraoral bone defects and one had a cylindrical metaphyseal
defect as the model (Table 2). In the study by Rismanchian et al., significantly better results (higher
amount of lamellar bone and woven bone) were obtained using blocks of forstrite than using bioglass
blocks, and both were better than unfilled controls in maxillary bone defects [41]. In a study on
periodontal osseous defects, blocks of Hydroxyapatite/β-tricalciumphosphate (HA/β-TCP) with
different macroporosity (ratio from 100/0 to 0/100) and biphasic calcium phosphate ceramic were
compared to unfilled controls [43]. After six months, the better results (gain in attachment level and
bone defect regeneration) were obtained using the combination 85% HA/15% X.
Seven studies on rats were included (Table 3), of which three were on long bones [45–47], two
on the calvaria model [48,62], one on a postextraction maxillary socket [50], and one on ectopic
bone formation [49]. Some of the studies on long bones and calvaria used PLA (poly(l-lactic
acid))-based blocks that were demonstrated to be osteocompatible and to have good osteoconductive
properties [46,48,62]. The study of Billström et al. [49] showed that a material containing nanostructured
hydroxyapatite and BMP-2 can induce the formation of ectopic bone with a density higher than other
materials tested (β-TCP and different forms of HA).
All studies on minipigs were performed on intraoral models (Table 4). The studies by Yeo et
al. [51] and Kirchoff et al. [52] investigated mandibular ridge augmentation using autogenous bone
block plus collagen membrane as the control. The histomorphometric results of both studies showed
clear superiority of the control group at 5/10 weeks [53] and at 24 weeks. The study by Henkel et al.
evaluated different graft materials based on CaP fabricated with a sol/gel process at 700 ◦C versus
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HA/β-TCP ceramics, or a gelatin sponge in mandibular critical size defects (>5 cm3) [52]. The best
results in terms of bone formation and material resorption rate were achieved using CaP biomaterials
(> 93% bone formation versus < 58% with the classical ceramics), which also showed lower percentage
of residual material than HA/β-TCP ceramics after eight months [53].
The four studies performed on the goat model all investigated orthopedic defect types (Table 5).
The study of Nandi et al. on radius defects treated with porous bioactive glass blocks, as compared
to unfilled defects, showed well-organized and vascularized bone tissue after three months in the
test group [55]. Two studies on lumbar transverse process defects showed good osteoinductivity of
porous biphasic calcium phosphate ceramics (HA/β-TCP) with up to 12 weeks of orthotopic bone
healing [57], and a similar performance of brushite (dicalcium phosphate dehydrate) as compared to
monetite (dicalcium phosphate anhydrous) [56] in terms of orthotopic and ectopic bone formation for
up to 9 weeks.
Finally, two studies on the sheep model were included (Table 6). One evaluated β-TCP cylinders
with different pore sizes (150 nm, 260 nm, 510 nm, and 1220 nm) in methaphysial or epiphysial long
bone defects [59]. The best outcomes in terms of new bone formation were obtained with blocks having
260 nm pores. The second study was on the reconstruction of critical-size defects in the calvaria (five
defects of 16.8 mm diameter per animal), filled with blocks of four different materials (see Table 6) [60].
After one year of healing, the best result in terms of mean bone replacement, as determined by
computed tomography, was achieved in the group using a mixture of 20% hydroxyapatite-cement and
80% TCP (28.5 ± 4.5%).
3. Discussion
The purpose of the present investigation was to perform a systematic review and a meta-analysis
of in vivo studies that evaluated the efficacy of synthetic scaffolds in block form for bone regeneration.
We aimed at gathering the current evidence, assessing biomaterials’ performance and side effects, and
detecting knowledge gaps for the design of future clinical trials.
The outcome of the review highlights a wide heterogeneity of the studies included, presenting
differences in methodological model, procedural technique, and the type of biomaterials analyzed. The
studies selected for the present review included six animal species (rabbit, rat, dog, minipig, goat, and
sheep). Each species presents peculiar features, making interspecies comparison, as well as comparison
with bone regeneration in humans, quite difficult.
Using small-size animals like mice, rats, and rabbits carries some advantages, including easy
handling, relatively short time for bone healing, and low cost. Although rats are used extensively as
models for bone healing, they present consistent differences with human bone anatomy and physiology,
making them suitable only as a first-step approach, to demonstrate the biotolerance and safety of the
material. [65,66].
Conversely, rabbits have more similarities with human bone anatomy [65]. In particular, the bone
macro- and microarchitecture of the rabbit femoral condyle resemble the ones of implantation sites in
the human jawbone. For this reason, the rabbit is considered a valid model for preclinical studies on
dental implants [67].
As opposed to small animals, large-size animal models have more features in common with human
bone anatomy and/or physiology according to the literature [65,66,68]. Actually, small ruminants like
goat and sheep are suitable models for investigating orthopedic implants and prostheses due to long
bone and joint dimensions similar to humans. Furthermore, load bearing is very similar [65,68]. The
best animal model for studying bone regeneration is considered the minipig [69]. They have bone
architecture, anatomy, and bone healing rate very close to those of humans [65,70]. Also in dogs, bone
composition and structure have many features in common with humans. In the past 30 years, canine
models have been often used in periodontology and implant dentistry research [65]. However, using
the dog as an experimental model may raise some ethical issues.
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Large-size animal models present further drawbacks as compared to small-size animals, such as
high cost, seasonal breeding cycles (sheep), long time for bone healing, and requirement for appropriate
instrumentation and facilities [65,69].
In conclusion, the differences between the animal species, the size of the defects, and the
healing patterns represent sensible variables for the study outcome evaluation. When considering the
transferability of the results of the present review on synthetic bone blocks, some further consideration
regarding the limitations is needed. In addition to the above comments regarding transferability of
some animal models to humans, one should consider that the majority of the studies were performed
on experimentally created bone defects in healthy animals. This might produce a different healing
response as compared to diseased tissue in which the bone defect may be the consequence of a given
disease. In fact, the etiopathogenesis of diseases leading to bone defects creates a tissue environment
that is quite different from the one present in an experimentally induced bone defect.
Nevertheless, interesting indications could be drawn from the meta-analysis of studies on the rabbit
model, which clearly showed a favorable effect of synthetic blocks, in terms of new bone formation.
Our results confirmed that the biomechanical features of the synthetic bone substitutes could
play a key role in bone regeneration, as they showed improved regenerative properties in qualitative
and quantitative terms, as compared to sham control groups. In fact, these features suggest that
the concept of three-dimensional architecture of the microstructure and the chemical nature of the
scaffold could produce a determinant positive influence in the regenerative process and in newly
formed bone tissue features. In this way, some features that an ideal biomaterial should possess can be
identified [71–73]. For example, there should be an adequate porosity ensuring interconnection among
pores of an adequate size, in order to allow for diffusion of bone cells and nutrients and exchange of
waste products throughout the whole graft. The size of pores should be of at least 100 microns, though
>300 microns is the recommended size for allowing neoangiogenesis and formation of new bone [74].
Another important feature is the interface between the material and the environment in which the
material is embedded, in terms of both surface area (which is depending on the material porosity) and
surface texture. Both are critical for allowing optimal vascular ingrowth, bone cell adhesion, migration,
and proliferation. A third important property of the ideal graft material is an adequate mechanical
compressive strength and flexibility, in order to absorb loading forces from the surrounding hard and
soft tissues, especially in noncontained defects. This is particularly relevant in appositional grafts, like
most of the block grafts considered in the present review. Finally, the stability of the biodegradable
synthetic biomaterials while promoting bone ingrowth and the substitution of the graft with new bone
tissue is another essential feature [6–10,12]. In fact, the biomaterial degradation should not occur faster
than replacement with new bone, so that the supporting function is ensured throughout the graft
maturation process. For example, Shim et al. showed in rabbit a significant increase of the new bone
density in polycaprolactone/polylactic-co-glycolic acid scaffold blended with tri-calcium phosphate
(a material with considerable elastic properties) at four and eight weeks compared to the unfilled
sites [30].
The surface chemistry of the bone block could also play an important role in relation to the
biomechanics and substitution capability of the biomaterial with the new bone, the physio-biology of
the regenerated tissues, and the healing time of the graft [64].
On the contrary, Gabbai-Armelin et al. [45] reported in rats an earlier and more consistent new
bone formation in the unfilled tibial defects at 15 days in comparison to the sites grafted with bioglass,
but no statistical differences in the subsequent experimental follow-up times of the study.
Rismanchian et al. [41] tested different synthetic scaffolds in dogs and highlighted that a
nanocomposite forstrite graft (Mg2SiO4) showed an increased capability of volume maintenance
and lamellar bone formation after the healing time if compared with the unfilled site in postextractive
socket defect, with a high bonding strength and fracture toughness. Previous studies confirmed that
the regenerative outcome of synthetic blocks depends on a combination of physico-chemical properties
that provide cell adhesion and proliferation, tissue ingrowth, and substitution with new vital bone [75].
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Tamimi et al. [27] reported no statistically significant differences in vertical bone augmentation
with autologous bone grafts and monetite blocks at eight weeks of healing in the rabbit calvarial model.
All of these studies’ findings suggest that the scaffold should be chosen in relation to its nature,
features, and biology, according to specific surgical applications and indications, in order to optimize
and improve the clinical outcome.
As confirmed by recent literature, the optimal properties of the synthetic block depend on the
matching of biomechanical features of the scaffold, the regenerated bone, and the native tissue [76].
About the structure of biomaterials, several authors proposed that application of the graft in form
of either bone block or particulate may be equally effective for the treatment of bone atrophy [33,77–80].
Moreover, the surface chemistry of the bone block may play an important role in relation to the new
bone formation, improving the amount and composition of host protein adhering to a surface. In this
way, physical or chemical modifications have been proposed to improve biomaterial compatibility [81].
Troeltzsch et al. [82] reported that vertical augmentation was substantially higher when
space-making barrier materials such as titanium meshes were used. However, this was also associated
with a strong increase in complication rate [71]. When using block grafts, a higher horizontal gain, by
approximately 1 mm, was achieved [71].
Tolstunov et al. [83] classified the horizontal bone atrophies in the horizontal bone defect of Class
III–V (between 2 and 6 mm of thickness), suggesting that satisfying results may be achieved with the
use of the bone block graft techniques.
The treatment of the vertical and combined (vertical plus horizontal) defects with bone blocks may
present an increased difficulty also regarding the soft-tissue management. Clinically, it was reported to
be less predictable than when treating strictly horizontal defects in inlay/onlay protocols [9].
4. Materials and Methods
This systematic review and meta-analysis was performed and reported by following the preferred
reporting items for systematic reviews and meta-analysis (PRISMA) guidelines [24].
4.1. Search Strategy
A systematic literature review was performed on PubMed, Scopus, EMBASE electronic database
through the keywords: synthetic blocks, synthetic bone blocks, block graft, bone defects, bone
regeneration, reconstruction procedures, as the search paradigm, with no restrictions regarding
publication date. Appropriate search strategies were set for each database. The study pool was
then restricted to in vivo studies in which scaffold block grafting was reported. The last search was
performed on April 15, 2019. The reference list of the included studies and reviews was also evaluated
to find additional eligible articles not retrieved by the electronic search.
4.2. Inclusion Criteria
In vivo comparative studies assessing the outcome of synthetic block scaffold in bone regenerative
procedures were included. According to the search criteria, the experimental research had to include
study models in which the biomaterial was applied for the treatment of any type of bone defects. In vitro
studies were excluded, but if they also reported an in vivo study, they were taken into consideration.
No limitations about the type of synthetic blocks were applied to the research. Studies that did not
comply with the inclusion criteria, reviews, clinical case reports, case series, and in vitro studies were
excluded from the evaluation.
4.3. Selection of the Studies
The initial screening of the studies was performed independently by two experienced reviewers
(M.D.F. and M.T.) based on title and abstract. In the cases where abstracts were not available, the full
text was obtained and checked. Publications not conforming to the selection criteria were excluded.
Int. J. Mol. Sci. 2019, 20, 4221 15 of 20
Full text of all eligible articles was obtained and checked for inclusion criteria. For excluded articles,
the reasons for exclusion were recorded.
4.4. Data Extraction
Data from included articles were extracted and analyzed independently by the two authors,
following a specially designed data-collection form, which ensured systematic recording of data. The
aim was to evaluate quantitatively and qualitatively the outcome of the synthetic biomaterials blocks
in bone regenerative procedures. The primary outcomes were the percentage of new bone formation
and the percentage of residual bone. The secondary outcomes were the bone density at radiographic
analysis, the soft tissue health, and the postoperative complications. Other data were the sample size,
the gender, the duration of follow-up, the bone defect size and location, and the type of biomaterial
used in the test and in the control group.
4.5. Risk-of-Bias Analysis
The ARRIVE (Animals in Research: Reporting In Vivo Experiments) guidelines for reporting
animal experiments for assessing risk of bias and other methodological criteria were used to evaluate
the risk of bias of the animal studies included in this review. As no human study was found, no specific
risk-of-bias assessment tool for clinical trials was applied.
Quality criteria taken into consideration were as follows:
1. Ethical statement (nature of ethical review permissions and national or institutional guidelines
for the care and use of animals)
2. Experimental procedures (precise details of all procedures performed)
3. Experimental animals (details of animal used, including species, developmental stage or mean
age, type of teeth, and diagnosis)
4. Randomization
5. Allocation concealment
6. Blinding of the evaluator
7. Sample size calculation
8. Completeness of information on dropouts
9. Statistical analysis appropriateness
10. Financial conflict of interest
The evaluation of the methodological quality of the selected studies was performed by the
reviewers. All the criteria were assessed as adequate, unclear, or inadequate. The studies with at least
7/10 appropriate parameters and no inappropriate parameters were considered as low. Otherwise,
the studies were classified as high risk. The risk-of-bias analysis was performed using the software
RevMan Version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2014).
4.6. Meta-Analysis Inclusion Criteria
It was planned to perform a meta-analysis of the studies that compared a synthetic block vs. an
autologous block or a synthetic block vs. spontaneous healing. All articles that did not respect such
criteria were not included in the meta-analysis. The meta-analysis was performed only for studies
with similar comparisons reporting the same outcome measures. Mean differences were combined for
continuous data, using random-effects models if at least four studies were included in the meta-analysis,
while if there were less than four studies, a fixed-effects model was chosen. For split-mouth studies,
an intraclass correlation coefficient equal to zero was assumed. Also, when possible, subgroups
analysis was performed for studies presenting results at different time frames. The meta-analysis
was performed using the software RevMan Version 5.3. The outcome variable considered for the
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meta-analysis was the percentage of new bone formation in test and control sites with the use of a
histomorphometric analysis.
5. Conclusions
In conclusion, synthetic bone blocks represent a viable resource in bone regenerative surgery
to achieve new bone formation and minimize the risks of infection transmission. The physical and
biological properties of the synthetic scaffold seem to improve the new bone formation in experimental
defects in vivo. The advances in modern biomaterials science may allow enhancing the predictability
of regenerated bone quality and quantity for the treatment of maxillary bony defect.
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